Jove
Visualize
Contact Us

Related Experiment Videos

Gatifloxacin-associated acute hepatitis.

N E Henann1, M F Zambie

  • 1College of Pharmacy University of Louisiana at Monroe, and St. Francis Medical Center, 71209, USA.

Pharmacotherapy
|January 5, 2002
PubMed
Summary

Gatifloxacin, an antibiotic, can cause acute hepatitis, a serious liver inflammation. This case highlights the importance of monitoring liver function in patients taking this fluoroquinolone medication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The state of allergic diseases, 2001.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society·2001
Same author

Drug-food interactions in clinical practice.

The Journal of family practice·1995
Same author

Possible severe thrombocytopenia associated with a single dose of plicamycin.

The Annals of pharmacotherapy·1992
Same author

Possible hemolytic anemia associated with human insulin therapy.

DICP : the annals of pharmacotherapy·1990
Same author

I.v. alcohol in prevention of delirium tremens.

DICP : the annals of pharmacotherapy·1990
Same author

Survey of required clinical pharmacy textbooks.

DICP : the annals of pharmacotherapy·1989
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Pharmacology
  • Hepatology
  • Infectious Diseases

Background:

  • Gatifloxacin is a widely used fluoroquinolone antibiotic with broad-spectrum activity.
  • Concerns exist regarding adverse drug reactions associated with fluoroquinolone use.

Observation:

  • A 44-year-old female patient presented with symptoms of nausea, lethargy, and abdominal pain after 5 days of gatifloxacin treatment for chronic sinusitis.
  • Clinical presentation included elevated liver function tests and jaundice, with bilirubin peaking at 9.4 mg/dl.

Findings:

  • Percutaneous liver biopsy revealed acute hepatitis with eosinophilic infiltrates, strongly suggesting drug-induced hepatitis.
  • Other potential causes for hepatitis, including alternative medications and disease processes, were systematically excluded.

Implications:

  • This case underscores the potential hepatotoxicity of gatifloxacin.
  • Healthcare providers should maintain a high index of suspicion for gatifloxacin-induced hepatitis and monitor liver function in patients receiving this antibiotic.

Related Experiment Videos